Form D · Biotechnology
VAIL SCIENTIFIC, INC.
Bloomington, MN · CIK 0001871154
Offering snapshot reported Mar 13, 2025 · SEC filing
- Reported sold
- $7M Offering amount: $7M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 19, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 13, 2025 | Initial | $7,000,000 | No comparison | 13 | SEC filing |
| Dec 6, 2023 | Initial | $400,000 | No comparison | 2 | SEC filing |
| Aug 11, 2021 | Initial | $680,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-540799
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| The Oak Ridge Financial Services Group, Inc. | 42941 |
Source: Form D, filed Mar 13, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carter R Anderson | Director |
| Clayton J Anderson | Director, Executive |
| Tom Burke | Director, Executive |
| Thomas W. Burke | Executive |
| Curtis Carlson | Director |
| Russell Morris | Director |
| Michael Nathan | Director |
| Joshua Robinson | Director |
| Josh Waldman | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7800 Metro Parkway, Suite 105
Bloomington, MN, 55425
Bloomington, MN, 55425